VetStem - Regenerative Cells

VetStem Regenerative Cells – Key Safety Factors: Autologous (from the patient back to the same patient): Tissue reaction risk is minimized. Minimally manipulated: Cells are not differentiated or modified. Accurate determination of each dose. Quality assessment of each dose. VetStem employs stringent processing protocols and quality control methods. Hundreds of publications support the safety of autologous cell therapy in animals. Reported canine adverse reaction rate is 0.1%. Reported equine adverse reaction rate is 0.2%. Reported feline adverse reaction rate is 0.3%.